Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-25
2005-10-25
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S366000
Reexamination Certificate
active
06958337
ABSTRACT:
The crystalline polymorph Form I of (−)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one represented by the formula Ipharmaceutical compositions containing such a polymorph and methods of using such a polymorph to treat fungal infections in mammals are disclosed.
REFERENCES:
patent: 6713481 (2004-03-01), Andrews et al.
Andrews David R.
Leong William
Sudhakar Anantha
Bernhardt Emily
Reinhardt Gerard E.
Schering Corporation
LandOfFree
Crystalline antifungal polymorph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline antifungal polymorph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline antifungal polymorph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464558